MRNS
Marinus Pharmaceuticals Inc
Price:  
0.55 
USD
Volume:  
890,389.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

MRNS WACC - Weighted Average Cost of Capital

The WACC of Marinus Pharmaceuticals Inc (MRNS) is 5.6%.

The Cost of Equity of Marinus Pharmaceuticals Inc (MRNS) is 6.75%.
The Cost of Debt of Marinus Pharmaceuticals Inc (MRNS) is 7.00%.

Range Selected
Cost of equity 5.50% - 8.00% 6.75%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 7.00% - 7.00% 7.00%
WACC 5.3% - 6.0% 5.6%
WACC

MRNS WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.35 0.56
Additional risk adjustments 0.0% 0.5%
Cost of equity 5.50% 8.00%
Tax rate 26.20% 27.00%
Debt/Equity ratio 2.44 2.44
Cost of debt 7.00% 7.00%
After-tax WACC 5.3% 6.0%
Selected WACC 5.6%